{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:16:22Z","timestamp":1783667782356,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research at King Khalid University","doi-asserted-by":"crossref","award":["RGP.1\/278\/44"],"award-info":[{"award-number":["RGP.1\/278\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03073-w","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T17:43:08Z","timestamp":1760636588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selectively targeting the IKK\u03b2 by 11,11\u2019-methylenebisdibenzo[a, c]phenazine (SIKB-7543) downregulates aberrant NF-\u03baB signaling to control the proliferation and induce apoptosis in Hodgkin lymphoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Mohammad","family":"Abohassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesfer Mohammad","family":"Al Shahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Khaled","family":"AlOuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"3073_CR1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221149245","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Mu W, Xiao M. Genetic lesions and targeted therapy in Hodgkin lymphoma. Ther Adv Hematol. 2023;14:20406207221149245.","journal-title":"Ther Adv Hematol"},{"key":"3073_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092153","author":"F Jardin","year":"2022","unstructured":"Jardin F. NFkB pathway and Hodgkin lymphoma. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10092153.","journal-title":"Biomedicines"},{"key":"3073_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6020038","author":"P Grondona","year":"2018","unstructured":"Grondona P, et al. NF-\u03baB activation in lymphoid malignancies: genetics, signaling, and targeted therapy. Biomedicines. 2018. https:\/\/doi.org\/10.3390\/biomedicines6020038.","journal-title":"Biomedicines"},{"key":"3073_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fimmu.2020.01387","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, et al. The NF-\u03baB signaling pathway, the microbiota, and gastrointestinal tumorigenesis: recent advances. Front Immunol. 2020;11:1387.","journal-title":"Front Immunol"},{"issue":"4","key":"3073_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/jcb.21707","volume":"104","author":"J Plati","year":"2008","unstructured":"Plati J, Bucur O, Khosravi-Far R. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities. J Cell Biochem. 2008;104(4):1124\u201349.","journal-title":"J Cell Biochem"},{"issue":"3","key":"3073_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"A Isra\u00ebl","year":"2010","unstructured":"Isra\u00ebl A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol. 2010;2(3):a000158.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"3073_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/embr.201337983","volume":"15","author":"M Hinz","year":"2014","unstructured":"Hinz M, Scheidereit C. The I\u03baB kinase complex in NF-\u03baB regulation and beyond. EMBO Rep. 2014;15(1):46\u201361.","journal-title":"EMBO Rep"},{"issue":"2","key":"3073_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.blre.2016.10.001","volume":"31","author":"L Yu","year":"2017","unstructured":"Yu L, et al. NF-\u03baB signaling pathway and its potential as a target for therapy in lymphoid neoplasms. Blood Rev. 2017;31(2):77\u201392.","journal-title":"Blood Rev"},{"key":"3073_CR9","doi-asserted-by":"crossref","unstructured":"Duong-Ly, K.C. and J.R. Peterson, The human kinome and kinase inhibition. Curr Protoc Pharmacol, 2013. Chapter 2: p. Unit2.9.","DOI":"10.1002\/0471141755.ph0209s60"},{"issue":"9","key":"3073_CR10","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/jth.14225","volume":"16","author":"BME Tullemans","year":"2018","unstructured":"Tullemans BME, Heemskerk JWM, Kuijpers MJE. Acquired platelet antagonism: off-target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors. J Thromb Haemost. 2018;16(9):1686\u201399.","journal-title":"J Thromb Haemost"},{"issue":"20","key":"3073_CR11","doi-asserted-by":"publisher","first-page":"10911","DOI":"10.1080\/07391102.2023.2259483","volume":"42","author":"V Rajendran","year":"2024","unstructured":"Rajendran V, Ponnuraj K. High-throughput virtual screening and molecular dynamics simulation reveal NPC170742 a novel chalconoid compound as a potential inhibitor of D-glycero-D-manno-heptose-1,7-bisphosphate 7-phosphatase in Helicobacter pylori. J Biomol Struct Dyn. 2024;42(20):10911\u201321.","journal-title":"J Biomol Struct Dyn"},{"issue":"8","key":"3073_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14178","volume":"46","author":"M Abohassan","year":"2022","unstructured":"Abohassan M, et al. Gc\/ms characterization and computational kinome-wide screening of pomegranate fruit extract identifies key phytochemicals interacting to CDK kinases implicated in acute myeloid leukemia cells. J Food Biochem. 2022;46(8):e14178.","journal-title":"J Food Biochem"},{"issue":"12","key":"3073_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10822-021-00426-1","volume":"35","author":"M Al Shahrani","year":"2021","unstructured":"Al Shahrani M, et al. High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf\/c-Raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma. J Comput Aided Mol Des. 2021;35(12):1165\u201376.","journal-title":"J Comput Aided Mol Des"},{"issue":"12","key":"3073_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12032-022-01846-1","volume":"39","author":"M Abohassan","year":"2022","unstructured":"Abohassan M, et al. Insilco and Invitro approaches identify novel dual PI3K\/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations. Med Oncol. 2022;39(12):249.","journal-title":"Med Oncol"},{"key":"3073_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108180","volume":"112","author":"N Ercin","year":"2024","unstructured":"Ercin N, Besli N, Kilic U. Uncovering the antidiabetic potential of heart-friendly and diuretic bioactive compounds through computer-based drug design. Comput Biol Chem. 2024;112:108180.","journal-title":"Comput Biol Chem"},{"key":"3073_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae416","author":"K Swanson","year":"2024","unstructured":"Swanson K, et al. ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries. Bioinformatics. 2024. https:\/\/doi.org\/10.1093\/bioinformatics\/btae416.","journal-title":"Bioinformatics"},{"issue":"4","key":"3073_CR17","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/cbdd.13705","volume":"96","author":"S Ansar","year":"2020","unstructured":"Ansar S, Vetrivel U. KinomeRun: an interactive utility for kinome target screening and interaction fingerprint analysis towards holistic visualization on kinome tree. Chem Biol Drug Des. 2020;96(4):1162\u201375.","journal-title":"Chem Biol Drug Des"},{"issue":"2","key":"3073_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"key":"3073_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151225","volume":"746","author":"M Al Shahrani","year":"2025","unstructured":"Al Shahrani M, et al. Identification of 8-(2-methyl phenyl)-9H-benzo[f]indeno[2,1-c]quinolin-9-one (C-5635020) as a novel and selective TGF\u03b2 RII kinase inhibitor for breast cancer therapy. Biochem Biophys Res Commun. 2025;746:151225.","journal-title":"Biochem Biophys Res Commun"},{"key":"3073_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, et al. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"key":"3073_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11030310","author":"P B\u0105ska","year":"2022","unstructured":"B\u0105ska P, Norbury LJ. The role of nuclear factor kappa B (NF-\u03baB) in the immune response against parasites. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11030310.","journal-title":"Pathogens"},{"issue":"6","key":"3073_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3073_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050788","author":"K Deka","year":"2023","unstructured":"Deka K, Li Y. Transcriptional regulation during aberrant activation of NF-\u03baB signalling in cancer. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12050788.","journal-title":"Cells"},{"key":"3073_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells7110189","author":"R Kennedy","year":"2018","unstructured":"Kennedy R, Klein U. Aberrant activation of NF-\u03baB signalling in aggressive lymphoid malignancies. Cells. 2018. https:\/\/doi.org\/10.3390\/cells7110189.","journal-title":"Cells"},{"issue":"4","key":"3073_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1476-5381.2011.01608.x","volume":"165","author":"C Gamble","year":"2012","unstructured":"Gamble C, et al. Inhibitory kappa b kinases as targets for pharmacological regulation. Br J Pharmacol. 2012;165(4):802\u201319.","journal-title":"Br J Pharmacol"},{"issue":"W1","key":"3073_CR26","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 2024;52(W1):W422\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3073_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2025.108347","author":"A Bhattacharjee","year":"2025","unstructured":"Bhattacharjee A, Kar S, Ojha PK. Ligand-based cheminformatics and free energy-inspired molecular simulations for prioritizing and optimizing G-protein coupled receptor kinase-6 (GRK6) inhibitors in multiple myeloma treatment. Comput Biol Chem. 2025. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108347.","journal-title":"Comput Biol Chem"},{"issue":"5","key":"3073_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10(5):449\u201361.","journal-title":"Expert Opin Drug Discov"},{"issue":"19","key":"3073_CR29","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1158\/1078-0432.CCR-05-2501","volume":"12","author":"T Hideshima","year":"2006","unstructured":"Hideshima T, et al. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo. Clin Cancer Res. 2006;12(19):5887\u201394.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3073_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.joim.2019.09.004","volume":"17","author":"MMM Abou-Hashem","year":"2019","unstructured":"Abou-Hashem MMM, et al. Induction of sub-G(0) arrest and apoptosis by seed extract of Moringa peregrina (Forssk.) Fiori in cervical and prostate cancer cell lines. J Integr Med. 2019;17(6):410\u201322.","journal-title":"J Integr Med"},{"issue":"4","key":"3073_CR31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1039\/D0MD00361A","volume":"12","author":"J Cheng","year":"2021","unstructured":"Cheng J, et al. Pharmacological inhibition of NF-\u03baB-inducing kinase (NIK) with small molecules for the treatment of human diseases. RSC Med Chem. 2021;12(4):552\u201365.","journal-title":"RSC Med Chem"},{"key":"3073_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5948170","volume":"2024","author":"A Alfaifi","year":"2024","unstructured":"Alfaifi A, et al. Advancements in B-cell non-Hodgkin\u2019s lymphoma: from signaling pathways to targeted therapies. Adv Hematol. 2024;2024:5948170.","journal-title":"Adv Hematol"},{"issue":"Suppl","key":"3073_CR33","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/j.clml.2015.02.002","volume":"15","author":"PB da Silva","year":"2015","unstructured":"da Silva PB, et al. Imbalance of Pro- and Anti-Inflammatory Cytokines in Patients With cHL Persists Despite Treatment Compared With Control Subjects. Clin Lymphoma Myeloma Leuk. 2015;15(Suppl):S151\u20137.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"3073_CR34","first-page":"1323","volume":"21","author":"Y Gu","year":"2010","unstructured":"Gu Y, et al. Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control. 2010;21(8):1323\u201333.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"3073_CR35","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1074\/jbc.M209677200","volume":"278","author":"JR Burke","year":"2003","unstructured":"Burke JR, et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2003;278(3):1450\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"3073_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1124\/jpet.104.074484","volume":"312","author":"PL Podolin","year":"2005","unstructured":"Podolin PL, et al. Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation. J Pharmacol Exp Ther. 2005;312(1):373\u201381.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"3073_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-065X.2012.01099.x","volume":"246","author":"JA DiDonato","year":"2012","unstructured":"DiDonato JA, Mercurio F, Karin M. NF-\u03baB and the link between inflammation and cancer. Immunol Rev. 2012;246(1):379\u2013400.","journal-title":"Immunol Rev"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03073-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:31:09Z","timestamp":1762425069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03073-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3073"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03073-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval, Consent to Participate, Human and Animal Rights"}},{"value":"The authors give their consent to the journal for the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"519"}}